Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10438393rdf:typepubmed:Citationlld:pubmed
pubmed-article:10438393lifeskim:mentionsumls-concept:C0085501lld:lifeskim
pubmed-article:10438393lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:10438393lifeskim:mentionsumls-concept:C0042232lld:lifeskim
pubmed-article:10438393lifeskim:mentionsumls-concept:C1522570lld:lifeskim
pubmed-article:10438393lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:10438393lifeskim:mentionsumls-concept:C1704264lld:lifeskim
pubmed-article:10438393lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:10438393pubmed:issue3lld:pubmed
pubmed-article:10438393pubmed:dateCreated1999-9-23lld:pubmed
pubmed-article:10438393pubmed:abstractTextThe relationship between polymorphisms in the interleukin-1 receptor antagonist (IL-1ra) gene and microbial vaginal colonization was examined in 88 asymptomatic women of reproductive age. Alleles of the intron 2 region of the IL-1ra gene were identified by polymerase chain reaction (PCR). PCR was also used to detect Ureaplasma urealyticum, Mycoplasma hominis, and Candida albicans; bacterial vaginosis (BV) was identified by clinical criteria. Among the 31 women with vaginal U. urealyticum, only 3 (9.7%) were homozygous for allele 2 of the IL-1ra gene; 21 (36.8%) of the 57 women who were negative for this organism were positive for allele 2 (P=.006). Only 7 women were positive for M. hominis; none were allele 2 homozygotes as opposed to 24 (29.6%) of the 81 women negative for M. hominis. There was no relation between C. albicans or BV and any IL-1ra allele. Reduced susceptibility to vaginal colonization with mycoplasmas may be associated with homozygosity of the 2 allele of the IL-1ra gene.lld:pubmed
pubmed-article:10438393pubmed:languageenglld:pubmed
pubmed-article:10438393pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438393pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10438393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438393pubmed:statusMEDLINElld:pubmed
pubmed-article:10438393pubmed:monthSeplld:pubmed
pubmed-article:10438393pubmed:issn0022-1899lld:pubmed
pubmed-article:10438393pubmed:authorpubmed-author:WitkinS SSSlld:pubmed
pubmed-article:10438393pubmed:authorpubmed-author:GiraldiVVlld:pubmed
pubmed-article:10438393pubmed:authorpubmed-author:JeremiahGGlld:pubmed
pubmed-article:10438393pubmed:authorpubmed-author:DurrantSSlld:pubmed
pubmed-article:10438393pubmed:authorpubmed-author:Ribeiro-Filho...lld:pubmed
pubmed-article:10438393pubmed:issnTypePrintlld:pubmed
pubmed-article:10438393pubmed:volume180lld:pubmed
pubmed-article:10438393pubmed:ownerNLMlld:pubmed
pubmed-article:10438393pubmed:authorsCompleteYlld:pubmed
pubmed-article:10438393pubmed:pagination912-4lld:pubmed
pubmed-article:10438393pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:meshHeadingpubmed-meshheading:10438393...lld:pubmed
pubmed-article:10438393pubmed:year1999lld:pubmed
pubmed-article:10438393pubmed:articleTitleRelationship between Ureaplasma urealyticum vaginal colonization and polymorphism in the interleukin-1 receptor antagonist gene.lld:pubmed
pubmed-article:10438393pubmed:affiliationDivision of Immunology and Infectious Diseases, Department of Obstetrics and Gynecology, Weill Medical College of Cornell University, New York, New York 10021, USA.lld:pubmed
pubmed-article:10438393pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10438393pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10438393pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438393lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438393lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438393lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438393lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438393lld:pubmed